OPB-31121

OPB-31121 · Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for OPB-31121, covering 2008-04-18 to 2025-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma [Phase 1]

See pricing